Skip to main content

PD-1 and PD-L1 Inhibitor Market Future Business Opportunities 2023-2028 | Pfizer Inc., Novartis AG, AstraZeneca PLC

 


The global PD-1 and PD-L1 inhibitor market was valued at US$ 30,535.5 Mn in 2021 and is forecast to reach a value of US$ 77,541.1 Mn by 2028 at a CAGR of 14.2% between 2022 and 2028. The global PD-1 and PD-L1 inhibitor market is experiencing strong growth due to the rise in incidence or prevalence of cancer and growing geriatric population around the world. Moreover, increase in awareness among people about immune checkpoint inhibitors is expected to boost the growth of the market. However, high cost of cancer treatment and risk of complications associated with the treatment is expected to hamper growth of the global PD-1 and PD-L1 inhibitor market.

Global PD-1 and PD-L1 Inhibitor Market: Regional Insights

Based on geography, the PD-1 and PD-L1 inhibitor market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period owing to the increasing prevalence of cancer and favourable initiatives by the regulatory authorities in the region, especially in the United States. For instance, PD-1 and PD-L1 inhibitors are vital immune checkpoint inhibitors used to treat variety of cancer. According to the American Cancer Society, in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. This in turn is expected to increase demand for PD-1 and PD-L1 inhibitors in the region.

Asia Pacific is also expected to witness significant growth in the global PD-1 and PD-L1 inhibitor market owing to the high prevalence of cancer together with growing geriatric population in this region, especially in India. For instance, according to the cancer report by the Indian Council of Medical Research (ICMR), India’s cancer cases could increase by 12% in the next five years, with 1.5 million people projected to suffer from the non-communicable disease by 2025, up from 1.39 million in 2020. This in turn is expected to increase demand for PD-1 and PD-L1 inhibitors.

Global PD-1 and PD-L1 Inhibitor Market Restraints:

High cost of cancer treatment is expected to hamper growth of the global PD-1 and PD-L1 inhibitor market. For instance, on average, the cost of cancer treatment in India is around INR 503,118 (US$ 6,300) with a minimum expense of INR 90,561 (US$ 1,134) and maximum cost of INR 27,67,149 (USD 34,650). Moreover, the cost of available PD-1 and PD-L1 inhibitors is high, however, the cost of cancer treatment depends on the stage of the cancer.

 

Comments

Popular posts from this blog

The Global Autoclave Equipment Market Continues To Grow Owing To the Rising Demand from Healthcare Sectors for Sterilizing Medical Equipment to Ensure the Safety of the Post-Surgical Period

  Autoclave equipment is the most popular sterilization method in the industry and is used for many applications including the manufacture of food products. It is widely used in the foodservice industry to sterilize and cleanse equipment used in the process of preparing and serving food. The autoclave is the abbreviated form of autolysis which means oxidation. Autoclaves have various parts including an electric motor, a condenser, and a burner. Autoclave equipment includes vials for sealing the autoclave, a glass or plastic container that has been lined with wax or plastic, and the appropriate autoclave equipment accessories such thermometer for measuring the temperature of the autoclave. All modern steam sterilizing equipment & autoclave machines provide a much-refined workflow experience, which makes you reconsider whether or not steam sterilizing is all it can be. A wide range of sterilization methods is used for sterilizing your medical and laboratory specimen so the right ...

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...